Switching to Doravirine in cART-Experienced Patients: An Effective and Highly Tolerated Option With Substantial Cost Savings
Journal of acquired immune deficiency syndromes (1999), 2024-02, Vol.95 (2), p.190-196 [Peer Reviewed Journal]Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved. ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/QAI.0000000000003337 ;PMID: 37963350
Digital Resources/Online E-Resources